ArticleFrontiers in medicine2025
Development of a machine learning model for hepatic steatosis screening using non-invasive Traditional Chinese Medicine diagnostics and clinical variables: a health checkup study with community screening potential.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Steatotic liver disease (SLD), underpinned by hepatic steatosis, is a global health concern affecting approximately 30% of the population. Current screening methods primarily rely on laboratory tests and lack broad-spectrum applicability. This study aims to develop a predictive model by selecting from non-invasive Traditional Chinese Medicine (TCM) diagnostics, demographic, and anthropometric variables to enhance early detection of hepatic steatosis. Methods: Data from 1,703 local residents undergoing health checkup at the health management center of Affiliated Hospital of Chengdu University of Traditional Chinese Medicine between December 2018 and December 2021 were analyzed. Demographic, anthropometric, and TCM diagnostic data were collected using questionnaires and standardized instruments. Hepatic steatosis was diagnosed via ultrasonography. Predictive models were developed using three parametric and six non-parametric algorithms, evaluated through nested five-fold stratified cross-validation. Performance was evaluated in terms of discrimination, classification metrics at the optimal threshold, calibration, and clinical utility. Results: Anthropometric variables body mass index (BMI), weight, diastolic blood pressure, and TCM diagnostic indicators HSV_H of nose, T5, phlegm-dampness constitution score, RGB_R of mid tongue, Lab_A of lip, T4, H5, and Lab_A of orbit, a total of 11 variables were selected as predictors. Logistic regression (AUC 0.83, 95% CI: 0.809-0.850) and XGBoost (AUC 0.84, 95% CI: 0.818-0.859) achieved the highest AUC among parametric and non-parametric models, respectively. XGBoost showed marginally better performance than logistic regression in AUC and clinical utility. Difference of classification metrics, calibration slops, and calibration intercepts of the two models was not statistically significant. SHAP analysis identified BMI and body weight as the most influential predictors, alongside substantial contributions from TCM features (HSV_H of nose and T5). Conclusion: TCM features combined with anthropometric variables can be used to develop a non-invasive screening model for ultrasound-diagnosed hepatic steatosis. Both the XGBoost and Logistic Regression models demonstrated robust performance, though external validation is needed to confirm generalizability. This non-invasive approach offers a practical tool with potential for hepatic steatosis screening in community settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.